| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $67.5M | +12.5% | +15.2% |
| Cost of Revenue | $38.5M | -32.1% | -3.4% |
| R&D Expense | $75.2M | -5.3% | +10.2% |
| SG&A Expense | $34.6M | -8.3% | -12.6% |
| Operating Income | -$94.9M | +16.6% | -6.6% |
| Pre-tax Income | -$93.7M | +14.6% | -10.1% |
| Income Tax | -$2.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $158.1M | +19.4% | -3.7% |
| Short-term Investments | $142.7M | -15.4% | -38.8% |
| Accounts Receivable | $66.8M | +11.4% | +19.7% |
| Inventory | $51.7M | +3.8% | +34.0% |
| Current Assets | $429.1M | +1.6% | -13.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$249.8M | — | — |
| Capital Expenditures | $24.5M | — | — |
| Investing Cash Flow | $46.7M | — | — |
| Financing Cash Flow | $244.6M | — | — |
| Free Cash Flow | -$274.4M | — | — |
| -221.0% |
| -58.2% |
| Net Income | -$91.3M | +18.3% | -9.2% |
| EPS (Basic) | -$0.25 | +24.2% | +10.7% |
| $904.9M |
| -0.3% |
| -8.7% |
| Current Liabilities | $125.8M | -2.6% | +6.5% |
| Total Liabilities | $202.7M | -3.0% | -6.9% |
| Stockholders' Equity | $702.3M | +0.5% | -9.2% |